Sarab Lizard

1.5k total citations
14 papers, 609 citations indexed

About

Sarab Lizard is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Sarab Lizard has authored 14 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Sarab Lizard's work include Lung Cancer Treatments and Mutations (4 papers), HER2/EGFR in Cancer Research (3 papers) and Sarcoma Diagnosis and Treatment (2 papers). Sarab Lizard is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), HER2/EGFR in Cancer Research (3 papers) and Sarcoma Diagnosis and Treatment (2 papers). Sarab Lizard collaborates with scholars based in France, Switzerland and Vietnam. Sarab Lizard's co-authors include Claude Turc‐Carel, Francine Mugneret, Irène Philip, I Sidaner, Thierry Philip, Christian Völk, Sylviane Olschwang, Alain Aurias, Jean Paul Thiery and Gilbert Lenoir and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Clinical Microbiology and Annals of Oncology.

In The Last Decade

Sarab Lizard

14 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarab Lizard France 6 403 152 148 134 118 14 609
Richard B. Mertens United States 15 146 0.4× 80 0.5× 351 2.4× 68 0.5× 53 0.4× 20 648
Stephen C. Somach United States 16 135 0.3× 128 0.8× 313 2.1× 73 0.5× 64 0.5× 36 638
Héctor A. Rodríguez-Martínez Mexico 10 161 0.4× 68 0.4× 179 1.2× 66 0.5× 36 0.3× 23 462
Antoine Dossier France 14 207 0.5× 82 0.5× 134 0.9× 87 0.6× 201 1.7× 40 658
Salima Haque United States 13 148 0.4× 106 0.7× 88 0.6× 49 0.4× 80 0.7× 32 533
Shingo Higaki Japan 15 232 0.6× 81 0.5× 269 1.8× 197 1.5× 44 0.4× 41 719
Meera Thomas India 11 101 0.3× 82 0.5× 278 1.9× 45 0.3× 64 0.5× 59 563
Tokichi Yumoto Japan 13 243 0.6× 49 0.3× 160 1.1× 45 0.3× 172 1.5× 53 521
Wing Y. Chan China 15 152 0.4× 253 1.7× 345 2.3× 150 1.1× 23 0.2× 25 802
Federico Serana Italy 16 51 0.1× 141 0.9× 145 1.0× 84 0.6× 34 0.3× 41 576

Countries citing papers authored by Sarab Lizard

Since Specialization
Citations

This map shows the geographic impact of Sarab Lizard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarab Lizard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarab Lizard more than expected).

Fields of papers citing papers by Sarab Lizard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarab Lizard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarab Lizard. The network helps show where Sarab Lizard may publish in the future.

Co-authorship network of co-authors of Sarab Lizard

This figure shows the co-authorship network connecting the top 25 collaborators of Sarab Lizard. A scholar is included among the top collaborators of Sarab Lizard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarab Lizard. Sarab Lizard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Beau‐Faller, Michèle, Matthieu Texier, Hélène Blons, et al.. (2018). Clinical Relevance of EGFR- or KRAS-mutated Subclones in Patients With Advanced Non–small-cell Lung Cancer Receiving Erlotinib in a French Prospective Cohort (IFCT ERMETIC2 Cohort - Part 2). Clinical Lung Cancer. 20(3). 222–230. 2 indexed citations
2.
Dumont, Pierre, et al.. (2017). Identification and validation of a factor of commutability between platelet counts performed on EDTA and citrate. Annales de biologie clinique. 75(1). 61–66. 7 indexed citations
3.
Riedinger, Jean‐Marc, Vincent Goussot, Isabelle Desmoulins, et al.. (2016). ACE et diagnostic précoce de récidive dans les différents sous-types moléculaires de cancer du sein : comparaison au CA 15-3. Bulletin du Cancer. 103(5). 434–443. 5 indexed citations
4.
Lizard, Sarab, Catherine Loustalot, Charles Coutant, et al.. (2016). The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?. Journal of Clinical Oncology. 34(15_suppl). e13116–e13116. 1 indexed citations
5.
Goussot, Vincent, Isabelle Desmoulins, Véronique Lorgis, et al.. (2015). Intérêt clinique du CA 15-3 dans la détection précoce des récidives de cancer du sein localement avancé. Bulletin du Cancer. 102(10). 834–844. 2 indexed citations
6.
7.
Beau‐Faller, Michèle, Nathalie Prim, Anne-Marie Ruppert, et al.. (2012). Rare epidermal growth factor receptor (EGFR) mutations in 10,117 patients with non-small cell lung cancer (NSCLC) evaluated by the French ERMETIC IFCT network: Clinical, molecular, and survival data.. Journal of Clinical Oncology. 30(15_suppl). 10507–10507. 5 indexed citations
8.
Cadranel, Jacques, Michèle Beau‐Faller, Audrey Mauguen, et al.. (2009). Biological and clinical prognostic factors in patients with advanced non-small-cell cancer (NSCLC) treated by erlotinib: Preliminary results of the ERMETIC cohort. Journal of Clinical Oncology. 27(15_suppl). 8079–8079. 1 indexed citations
9.
Dalle, Frédéric, Laure Dumont, Denis Caillot, et al.. (2003). Genotyping of Candida albicans Oral Strains from Healthy Individuals by Polymorphic Microsatellite Locus Analysis. Journal of Clinical Microbiology. 41(5). 2203–2205. 30 indexed citations
10.
Buron, Nelly, Éric Solary, Sarab Lizard, et al.. (2003). [Trefoil factor family gene and peptide expression in pterygium].. PubMed. 26(10). 1007–14. 4 indexed citations
11.
Dalle, Frédéric, O. Vagner, Denis Caillot, et al.. (2000). Comparative Genotyping of Candida albicans Bloodstream and Nonbloodstream Isolates at a Polymorphic Microsatellite Locus. Journal of Clinical Microbiology. 38(12). 4554–4559. 49 indexed citations
12.
Champème, M.H., Ivan Bièche, Sarab Lizard, & Rosette Lidereau. (1995). 11q13 Amplification in local recurrence of human primary breast cancer. Genes Chromosomes and Cancer. 12(2). 128–133. 37 indexed citations
13.
Turc‐Carel, Claude, Alain Aurias, Francine Mugneret, et al.. (1988). Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases and remarkable consistency of t(11;22)(q24;q12). Cancer Genetics and Cytogenetics. 32(2). 229–238. 361 indexed citations
14.
Mugneret, Francine, Sarab Lizard, Alain Aurias, & Claude Turc‐Carel. (1988). Chromosomes in Ewing's sarcoma. II. Nonrandom additional changes, trisomy 8 and der(16)t(1;16). Cancer Genetics and Cytogenetics. 32(2). 239–245. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard B. Mertens Breakdown of academic impact, for papers by Stephen C. Somach Breakdown of academic impact, for papers by Héctor A. Rodríguez-Martínez Breakdown of academic impact, for papers by Antoine Dossier Breakdown of academic impact, for papers by Salima Haque Breakdown of academic impact, for papers by Shingo Higaki Breakdown of academic impact, for papers by Meera Thomas Breakdown of academic impact, for papers by Tokichi Yumoto Breakdown of academic impact, for papers by Wing Y. Chan Breakdown of academic impact, for papers by Federico Serana
Rankless by CCL
2026